HomeGSGTF • OTCMKTS
add
Gensight Biologics SA
Previous close
$0.19
Year range
$0.19 - $0.32
Market cap
19.69M EUR
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 24.00K | -97.22% |
Operating expense | 3.42M | -25.11% |
Net income | -3.48M | -19.13% |
Net profit margin | -14.51K | -4,188.80% |
Earnings per share | — | — |
EBITDA | -3.36M | 1.76% |
Effective tax rate | 0.13% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 270.00K | -96.11% |
Total assets | 7.35M | -50.95% |
Total liabilities | 39.46M | -0.91% |
Total equity | -32.11M | — |
Shares outstanding | 131.07M | — |
Price to book | -0.79 | — |
Return on assets | -115.46% | — |
Return on capital | 64.82% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.48M | -19.13% |
Cash from operations | -1.23M | 66.52% |
Cash from investing | -26.50K | -541.67% |
Cash from financing | 155.50K | -97.44% |
Net change in cash | -1.10M | -145.65% |
Free cash flow | -1.92M | -2.06% |
About
Founded
2012
Headquarters
Website
Employees
13
